|
|
||||||||
From the Department of Neurology (Drs. Cestari, Segal, and DeAngelis, D.M. Weine), Weill College of Medicine of Cornell University, and Departments of Neurology (Dr. DeAngelis) and Biostatistics (Dr. Panageas), Memorial SloanKettering Cancer Center, New York.
Address correspondence and reprint requests to Dr. L.M. DeAngelis, Memorial SloanKettering Cancer Center, 1275 York Ave., New York, NY 10021; e-mail: deangell{at}mskcc.org
Objective: To assess the incidence and type of strokes in patients with cancer at Memorial SloanKettering Cancer Center.
Methods: Retrospective review of all ischemic strokes diagnosed by a neurologist and confirmed by neuroimaging between February 1997 and April 2001 was conducted. Age, gender, cancer diagnosis and stage, and vascular risk factors were recorded. NIH Stroke Scale and modified Rankin Scale scores were calculated retrospectively. Stroke etiology was assigned independently by two neurologists using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
Results: Ninety-six patients with a confirmed stroke were identified. The median age was 67, and 61.5% were men. The distribution of vascular risk factors was comparable with that seen in large stroke trials. Lung cancer (30%) was the most common primary tumor followed by brain and prostate cancer (9% each). Strokes were embolic in 52 (54%) and nonembolic in 44 (46%). Eleven of 12 tested patients had an elevated D-dimer level, but in only 3 patients could a definitive diagnosis of nonbacterial thrombotic endocarditis be made. The median survival was 4.5 months (95% CI 2.8 to 9.5) from the diagnosis of stroke; 25% of patients died within 30 days. Treatment had no effect on survival.
Conclusions: Embolic strokes are the commonest cause of stroke in patients with cancer, due partially to hypercoagulability, whereas atherosclerosis accounted for only 22% of stroke in this population. Outcome was primarily determined by the underlying malignancy and the patients neurologic condition.
Received May 15, 2003. Accepted in final form January 29, 2004.
This article has been cited by other articles:
![]() |
T. N. Kreisl, T. Toothaker, S. Karimi, and L. M. DeAngelis Ischemic stroke in patients with primary brain tumors Neurology, June 10, 2008; 70(24): 2314 - 2320. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Whiteley and M. Dennis Confusion after a game of bridge Practical Neurology, October 1, 2007; 7(5): 342 - 345. [Full Text] [PDF] |
||||
![]() |
G. Singh, J. H Rees, and J. W Sander Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 342 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chang, M. Sarkiss, K. S. Won, J. Swafford, L. Broemeling, and I. Gayed Preoperative Risk Stratification Using Gated Myocardial Perfusion Studies in Patients with Cancer J. Nucl. Med., March 1, 2007; 48(3): 344 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Iguchi, K Kimura, K Kobayashi, Y Ueno, and T Inoue Ischaemic stroke with malignancy may often be caused by paradoxical embolism J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1336 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kikura, T. Takada, and S. Sato Preexisting Morbidity as an Independent Risk Factor for Perioperative Acute Thromboembolism Syndrome Arch Surg, December 1, 2005; 140(12): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |